pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·2h ago·1 min read
save

Hospitals file second lawsuit to block Trump admin's 340B rebate pilot

Oct 9, 2026·read at STAT ↗RegulatoryNegative

The American Hospital Association (AHA) has filed another lawsuit against the federal government, challenging a new version of the 340B drug discount program proposed by the Trump administration.

The administration's plan would replace the traditional upfront discounts with after-the-fact rebates for a set of high-cost, widely used Medicare drugs, expanding the list from 10 to 25 drugs and slated to begin on Jan. 1, 2027.

The AHA argues that the Health Resources and Services Administration (HRSA) did not properly account for the financial impact on hospitals, echoing the arguments that led a judge to temporarily block an earlier, narrower version of the program in 2025.

The lawsuit follows the earlier legal setback that caused the Health and Human Services Department to withdraw the initial proposal after an appeal, highlighting ongoing tension between hospital groups and the administration over 340B reforms.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “STAT+: Hospitals sue – again – to halt Trump administration’s 340B rebate pilot”

read at STAT ↗
573 words · retrieved 1h ago
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
Protara Therapeutics, Inc.7Life Biosciences Inc.

related stories

  • Jul 14STAT+: Hospital chain HCA warns of lower profits as more patients go uninsuredSTAT
  • Jul 13Caregivers brace for pay cuts, and maybe homelessnessSTAT
  • Jul 2STAT+: Medicare takes another swing at 340B cuts to hospitalsSTAT
  • Jun 295 takeaways from STAT’s investigation into microhospital operator Nutex HealthSTAT
  • Jun 18STAT+: Eli Lilly ends 340B drug discounts to some hospitals for failing to provide claims dataSTAT